Source 1primary paper2025MED
Toolkit/artificial intelligence
artificial intelligence
Also known as: AI
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Recent technological innovations, including ... artificial intelligence (AI) ... have created new opportunities for investigating the cellular and molecular basis of VDs. AI enhances data integration, risk prediction, and clinical interpretability.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
Objective: Map the research status, focal areas, and frontiers of ultrasound technology in medical applications using bibliometric analysis.
Why it works: The review first retrieves a defined literature corpus from Web of Science Core Collection and then applies bibliometric software to visualize multiple dimensions of the field, allowing hotspot and frontier identification from publication metadata and themes.
database retrievalbibliometric analysisknowledge-map visualization
Stages
- 1.Literature retrieval from Web of Science Core Collection(in_silico_filter)
This stage defines the publication corpus that will be analyzed bibliometrically.
Selection: relevant data on ultrasound technology in medical applications from the target time window
- 2.Bibliometric visualization and thematic mapping(functional_characterization)
This stage converts the retrieved literature corpus into interpretable maps of field structure and emerging topics.
Selection: visualization of authorship, geography, institutions, journals, and key themes using CiteSpace and VOSviewer
Steps
- 1.Interrogate Web of Science Core Collection for relevant ultrasound records
Assemble the literature dataset for the bibliometric review.
The review must first collect the relevant records before any bibliometric visualization can be performed.
- 2.Apply CiteSpace and VOSviewer to generate visualizations of field structure and themes
Produce visual summaries of authorship, geography, institutions, journals, and key article themes.
This analysis depends on the previously retrieved literature corpus.
Objective: Accelerate discovery and deployment of next-generation adjuvants through an integrated development pipeline.
Why it works: The proposed pipeline is expected to work by integrating production technologies, computational prioritization, and systematic immune characterization to speed discovery and deployment of adjuvants.
interaction with antigen-presenting cellsinflammasome activationT cell polarizationsynthetic biologyartificial intelligencesystematic immuno-profilingstructural modificationcombination with complementary immunostimulantsnanoparticle-based formulation
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete computational method used to design, rank, or analyze an engineered system.
Target processes
editingrecombinationInput: Light
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
AI enhances data integration, risk prediction, and clinical interpretability in vascular disease research.
Optogenetics and organ-on-chip platforms allow controlled manipulation and physiologically relevant modeling in vascular disease research.
Single-cell and spatial transcriptomics, super-resolution and photoacoustic imaging, microfluidic organ-on-chip platforms, CRISPR/Cas9-based gene editing, and AI have created new opportunities for investigating the cellular and molecular basis of vascular diseases.
These emerging technologies enable high-resolution mapping of cellular heterogeneity and functional alterations, facilitating biomarker discovery, disease modeling, and therapeutic development in vascular diseases.
Future progress in vascular disease research should prioritize multi-center large-scale validation studies, harmonization of assay protocols, and integration with clinical datasets and human samples.
Multi-omics approaches and computational modeling hold promise for unraveling disease complexity, and digital twins may accelerate personalized medicine in vascular disease research and treatment.
Integrating single-cell and multiomics approaches highlights disease-driving cell types and gene programs in vascular disease.
Approval Evidence
1 source4 linked approval claimsfirst-pass slug artificial-intelligence
Recent technological innovations, including ... artificial intelligence (AI) ... have created new opportunities for investigating the cellular and molecular basis of VDs. AI enhances data integration, risk prediction, and clinical interpretability.
Source:
capabilitysupports
AI enhances data integration, risk prediction, and clinical interpretability in vascular disease research.
Source:
capabilitysupports
Single-cell and spatial transcriptomics, super-resolution and photoacoustic imaging, microfluidic organ-on-chip platforms, CRISPR/Cas9-based gene editing, and AI have created new opportunities for investigating the cellular and molecular basis of vascular diseases.
Source:
capabilitysupports
These emerging technologies enable high-resolution mapping of cellular heterogeneity and functional alterations, facilitating biomarker discovery, disease modeling, and therapeutic development in vascular diseases.
Source:
future directionsupports
Future progress in vascular disease research should prioritize multi-center large-scale validation studies, harmonization of assay protocols, and integration with clinical datasets and human samples.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.